Nippon Life Global Investors Americas’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,070
| Closed | -$3.09M | – | 108 |
|
|
2023
Q4 | $3.09M | Hold |
32,070
| – | – | 0.17% | 77 |
|
|
2023
Q3 | $2.84M | Sell |
32,070
-215,210
| -87% | -$19M | 0.17% | 78 |
|
|
2023
Q2 | $21.4M | Sell |
247,280
-25,180
| -9% | -$2.18M | 1.45% | 19 |
|
|
2023
Q1 | $26.5M | Sell |
272,460
-13,950
| -5% | -$1.36M | 1.7% | 16 |
|
|
2022
Q4 | $29.6M | Buy |
286,410
+10,200
| +4% | +$1.06M | 1.96% | 12 |
|
|
2022
Q3 | $23.4M | Buy |
276,210
+57,430
| +26% | +$4.87M | 1.65% | 16 |
|
|
2022
Q2 | $18.1M | Hold |
218,780
| – | – | 1.17% | 24 |
|
|
2022
Q1 | $16.9M | Sell |
218,780
-10,620
| -5% | -$819K | 0.9% | 32 |
|
|
2021
Q4 | $20.3M | Sell |
229,400
-1,360
| -0.6% | -$120K | 0.96% | 27 |
|
|
2021
Q3 | $17.8M | Buy |
230,760
+17,580
| +8% | +$1.36M | 0.93% | 27 |
|
|
2021
Q2 | $17.8M | Sell |
213,180
-8,680
| -4% | -$724K | 0.89% | 30 |
|
|
2021
Q1 | $16.8M | Buy |
221,860
+7,640
| +4% | +$577K | 0.92% | 31 |
|
|
2020
Q4 | $18.8M | Hold |
214,220
| – | – | 1.12% | 25 |
|
|
2020
Q3 | $16.3M | Buy |
214,220
+7,210
| +3% | +$549K | 1.07% | 22 |
|
|
2020
Q2 | $25.5M | Sell |
207,010
-36,370
| -15% | -$4.49M | 1.82% | 11 |
|
|
2020
Q1 | $20.6M | Buy |
+243,380
| New | +$20.6M | 1.8% | 15 |
|